AI assistant
Sending…
BiomX Inc. — Director's Dealing 2018
Dec 21, 2018
35099_dirs_2018-12-21_a1d329cb-754f-4961-993e-e95864ed5d61.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Chardan Healthcare Acquisition Corp. (CHAC)
CIK: 0001739174
Period of Report: 2018-12-13
Reporting Person: Gnedy Elliot (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $0.0001 | 7500 | Direct |
More from BiomX Inc.
Transaction in Own Shares
2026
Jun 5
Board/Management Information
2026
May 28
Interim / Quarterly Report
2026
May 20
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 10
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 10
Regulatory Filings
2026
Apr 10
Capital/Financing Update
2026
Apr 1